The immunogenecity of biologics is a significant concern, which can affect safety and efficacy. In this interview with Dr. Eric Bonner, we explore recent developments in immunogenecity, highlight key challenges when reviewing immunogenecity, and explore current regulations.
Eurofins Bioanalytical Services expands its technology footprint with the addition of Quanterix® SR-X™. The Ultra-Sensitive Biomarker Detection, for the bench-top. Experience the unrivaled power of Simoa® single molecule digital detection technology now available in a compact size with increased workflow flexibility.